The Cigna Corp (CI)

$344.5

-12.68

(-3.55%)▲

Market is closed - opens 7 PM, 03 May 2024
star icon

Cigna Corp is a global health service company that provides medical, dental, and disability insurance plans.

Insights on The Cigna Corp

  • Increasing Revenue

    Revenue is up for the last 6 quarters, 45.19B → 51.08B (in $), with an average increase of 2.4% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 41.0M → 1.02B (in $), with an average increase of 96.0% per quarter

Performance

  • $343.02
    $361.15
    $344.50
    downward going graph

    0.43%

    Downside

    Day's Volatility :5.02%

    Upside

    4.61%

    downward going graph
  • $236.21
    $365.71
    $344.50
    downward going graph

    31.43%

    Downside

    52 Weeks Volatility :35.41%

    Upside

    5.8%

    downward going graph

Returns

PeriodThe Cigna CorpSector (Health Care)S&P500
3 Months
7.23%
-1.1%
2.1%
6 Months
10.9%
10.3%
16.2%
1 Year
40.04%
5.3%
23.8%
3 Years
36.68%
14.5%
20.8%

Highlights

Market Capitalization
99.9B
Book Value
$158.03
Dividend Share
4.92
Dividend Yield
1.59%
Earnings Per Share (EPS)
17.4
PE Ratio
20.25
PEG Ratio
0.89
Wall Street Target Price
383.14
Profit Margin
2.65%
Operating Margin TTM
4.49%
Return On Assets TTM
3.75%
Return On Equity TTM
11.79%
Revenue TTM
195.2B
Revenue Per Share TTM
664.15
Quarterly Revenue Growth YOY
11.600000000000001%
Gross Profit TTM
23.0B
EBITDA
10.7B
Diluted Eps TTM
17.4
Quarterly Earnings Growth YOY
-0.1
EPS Estimate Current Year
28.43
EPS Estimate Next Year
32.02
EPS Estimate Current Quarter
6.53
EPS Estimate Next Quarter
6.37

Analyst Recommendation

Buy
    61%Buy
    38%Hold
    0
    0%Sell
Based on 31 Wall street analysts offering stock ratings for The Cigna Corp(by analysts ranked 0 to 5 stars)
Based on 31 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
19
20
22
Hold
12
12
12
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 11.22%

Current $344.50
Target $383.14

Company Financials

FY18Y/Y Change
Revenue
48.6B
↑ 15.52%
Net Income
2.6B
↑ 17.88%
Net Profit Margin
5.43%
↑ 0.11%
FY19Y/Y Change
Revenue
153.7B
↑ 216.55%
Net Income
5.1B
↑ 93.55%
Net Profit Margin
3.32%
↓ 2.11%
FY20Y/Y Change
Revenue
160.6B
↑ 4.45%
Net Income
8.5B
↑ 65.71%
Net Profit Margin
5.27%
↑ 1.95%
FY21Y/Y Change
Revenue
174.3B
↑ 8.53%
Net Income
5.4B
↓ 36.51%
Net Profit Margin
3.08%
↓ 2.19%
FY22Y/Y Change
Revenue
180.6B
↑ 3.66%
Net Income
6.7B
↑ 24.84%
Net Profit Margin
3.71%
↑ 0.63%
FY23Y/Y Change
Revenue
195.2B
↑ 8.05%
Net Income
5.2B
↓ 22.97%
Net Profit Margin
2.65%
↓ 1.06%
Q3 FY22Q/Q Change
Revenue
45.2B
↓ 0.41%
Net Income
2.8B
↑ 77.07%
Net Profit Margin
6.1%
↑ 2.67%
Q4 FY22Q/Q Change
Revenue
45.8B
↑ 1.22%
Net Income
1.2B
↓ 57.6%
Net Profit Margin
2.56%
↓ 3.54%
Q1 FY23Q/Q Change
Revenue
46.5B
↑ 1.55%
Net Income
1.3B
↑ 8.38%
Net Profit Margin
2.73%
↑ 0.17%
Q2 FY23Q/Q Change
Revenue
48.6B
↑ 4.64%
Net Income
1.5B
↑ 15.23%
Net Profit Margin
3.0%
↑ 0.27%
Q3 FY23Q/Q Change
Revenue
49.0B
↑ 0.89%
Net Income
41.0M
↓ 97.19%
Net Profit Margin
0.08%
↓ 2.92%
Q4 FY23Q/Q Change
Revenue
51.1B
↑ 4.14%
Net Income
1.0B
↑ 2409.76%
Net Profit Margin
2.01%
↑ 1.93%
FY18Y/Y Change
Total Assets
153.2B
↑ 148.13%
Total Liabilities
112.2B
↑ 133.81%
FY19Y/Y Change
Total Assets
155.8B
↑ 1.66%
Total Liabilities
110.4B
↓ 1.57%
FY20Y/Y Change
Total Assets
155.5B
↓ 0.21%
Total Liabilities
105.1B
↓ 4.83%
FY21Y/Y Change
Total Assets
154.9B
↓ 0.36%
Total Liabilities
107.7B
↑ 2.51%
FY22Y/Y Change
Total Assets
143.9B
↓ 7.07%
Total Liabilities
99.0B
↓ 8.1%
FY23Y/Y Change
Total Assets
147.9B
↑ 2.77%
Total Liabilities
101.6B
↑ 2.62%
Q3 FY22Q/Q Change
Total Assets
144.2B
↓ 5.52%
Total Liabilities
99.1B
↓ 7.11%
Q4 FY22Q/Q Change
Total Assets
143.9B
↓ 0.19%
Total Liabilities
99.0B
↓ 0.1%
Q1 FY23Q/Q Change
Total Assets
148.0B
↑ 2.81%
Total Liabilities
103.4B
↑ 4.44%
Q2 FY23Q/Q Change
Total Assets
150.1B
↑ 1.4%
Total Liabilities
104.5B
↑ 1.11%
Q3 FY23Q/Q Change
Total Assets
149.6B
↓ 0.27%
Total Liabilities
103.9B
↓ 0.62%
Q4 FY23Q/Q Change
Total Assets
147.9B
↓ 1.15%
Total Liabilities
101.6B
↓ 2.22%
FY18Y/Y Change
Operating Cash Flow
3.8B
↓ 7.73%
Investing Cash Flow
-26.4B
↑ 1448.91%
Financing Cash Flow
23.5B
↓ 987.02%
FY19Y/Y Change
Operating Cash Flow
9.5B
↑ 151.59%
Investing Cash Flow
-734.0M
↓ 97.22%
Financing Cash Flow
-7.2B
↓ 130.56%
FY20Y/Y Change
Operating Cash Flow
10.4B
↑ 9.12%
Investing Cash Flow
3.0B
↓ 505.45%
Financing Cash Flow
-8.5B
↑ 18.73%
FY21Y/Y Change
Operating Cash Flow
7.2B
↓ 30.52%
Investing Cash Flow
-3.6B
↓ 221.34%
Financing Cash Flow
-8.2B
↓ 3.76%
FY22Y/Y Change
Operating Cash Flow
8.7B
↑ 20.37%
Investing Cash Flow
3.1B
↓ 185.79%
Financing Cash Flow
-11.2B
↑ 36.87%
Q3 FY22Q/Q Change
Operating Cash Flow
3.3B
↑ 163.91%
Investing Cash Flow
4.4B
↓ 1189.71%
Financing Cash Flow
-5.5B
↑ 502.29%
Q4 FY22Q/Q Change
Operating Cash Flow
2.1B
↓ 36.06%
Investing Cash Flow
3.1B
↓ 30.32%
Financing Cash Flow
-2.6B
↓ 52.22%
Q1 FY23Q/Q Change
Operating Cash Flow
5.0B
↑ 139.54%
Investing Cash Flow
-3.0B
↓ 196.29%
Financing Cash Flow
-37.0M
↓ 98.6%
Q2 FY23Q/Q Change
Operating Cash Flow
2.5B
↓ 50.44%
Investing Cash Flow
-414.0M
↓ 86.12%
Financing Cash Flow
-435.0M
↑ 1075.68%
Q3 FY23Q/Q Change
Operating Cash Flow
2.8B
↑ 13.4%
Investing Cash Flow
-4.7B
↑ 1043.48%
Financing Cash Flow
-2.6B
↑ 491.26%

Technicals Summary

Sell

Neutral

Buy

The Cigna Corp is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
The Cigna Corp
The Cigna Corp
-4.59%
10.9%
40.04%
36.68%
125.41%
Centene Corp.
Centene Corp.
1.77%
7.23%
8.16%
19.08%
41.34%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
7.23%
-7.14%
0.72%
21.45%
112.53%
Cvs Health Corporation
Cvs Health Corporation
-26.07%
-21.49%
-21.3%
-29.01%
-2.67%
Elevance Health, Inc
Elevance Health, Inc
3.88%
16.84%
14.72%
35.96%
100.84%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
The Cigna Corp
The Cigna Corp
20.25
20.25
0.89
28.43
0.12
0.04
0.02
158.03
Centene Corp.
Centene Corp.
14.95
14.95
0.68
6.77
0.11
0.04
NA
48.35
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
29.77
29.77
1.24
27.62
0.17
0.07
0.02
100.18
Cvs Health Corporation
Cvs Health Corporation
10.47
10.47
1.0
8.3
0.11
0.04
0.04
59.36
Elevance Health, Inc
Elevance Health, Inc
20.12
20.12
1.14
37.28
0.16
0.06
0.01
174.62
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
The Cigna Corp
The Cigna Corp
Buy
$99.9B
125.41%
20.25
2.65%
Centene Corp.
Centene Corp.
Buy
$39.6B
41.34%
14.95
1.91%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
Buy
$448.4B
112.53%
29.77
4.05%
Cvs Health Corporation
Cvs Health Corporation
Buy
$85.4B
-2.67%
10.47
2.34%
Elevance Health, Inc
Elevance Health, Inc
Buy
$124.0B
100.84%
20.12
3.64%

Institutional Holdings

  • Vanguard Group Inc

    8.73%

  • BlackRock Inc

    8.66%

  • FMR Inc

    5.12%

  • State Street Corporation

    4.77%

  • T. Rowe Price Associates, Inc.

    4.75%

  • Dodge & Cox

    4.66%

Corporate Announcements

  • The Cigna Corp Dividends March,2024

    In the quarter ending March,2024. The Cigna Corp has declared dividend of $1.4

    Read More

Company Information

The Cigna Group is a global health services company. The Companys portfolio of offerings solves diverse challenges across the healthcare system. The Company offers a differentiated set of pharmacy, medical, behavioral, dental and supplemental products, and services, primarily through two platforms: Evernorth Health Services and Cigna Healthcare.

Organization
The Cigna Corp
Employees
70325
CEO
Mr. David Michael Cordani
Industry
Health Services

Discover More

FAQs